J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, R.
Right arrow Articles by Bertrand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, R.
Right arrow Articles by Bertrand, K.

Articles

Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children

RD Brown, JT Wilson, GL Kearns, VF Eichler, VA Johnson, and KM Bertrand

The disposition of antipyretic drugs is central to the understanding of their action in children. Accordingly, the authors measured plasma levels of acetaminophen and ibuprofen in 153 febrile children for 6 hours after a single dose of either acetaminophen (12.5 mg/kg) or ibuprofen (5 or 10 mg/kg). Cmax occurred about 2 1/2 hours before maximum antipyresis, when plasma acetaminophen or ibuprofen was 25 to 50% less than Cmax. Most plasma level data fit a one-compartment open model, and this suggests a pharmacodynamic basis for the observed lag between Cmax and maximum antipyretic response. Plasma levels (and AUCO----infinity) of ibuprofen 10 mg/kg were less than expected for a two-fold increase in dose. For acetaminophen, the tlag was less than ibuprofen, Ka was more than ibuprofen, and beta was less than ibuprofen. The ibuprofen beta was not dose dependent, but the Vd was dose and model dependent. In contrast, ibuprofen Clp was dose and model independent. Acetaminophen pharmacokinetics were similar to those previously reported. Initial temperature, race, gender, prior medications, or diagnosis did not confound the results for ibuprofen or acetaminophen. Accordingly, a pharmacodynamic basis is a more likely explanation for the initial temperature effects found previously for antipyretic drugs in children. Ibuprofen (5 and 10 mg/kg) AUCO-----infinity was higher in the older (greater than or equal to 2.5 yrs) children and the Vd and Clp were lower in the older children, when discriminated by age or pharmacokinetic parameters. The observed dose dependency of AUCO----infinity and the effect of age on ibuprofen disposition must be considered if pharmacokinetic interpretations are used to develop the antipyretic dose of ibuprofen in children.


This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
I A Gibb and B J Anderson
Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration
Arch. Dis. Child., March 1, 2008; 93(3): 241 - 247.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
I Arranz, A Martin-Suarez, J M Lanao, F Mora, C Vazquez, A Escribano, M Juste, J Mercader, and E Ripoll
Population pharmacokinetics of high dose ibuprofen in cystic fibrosis
Arch. Dis. Child., December 1, 2003; 88(12): 1128 - 1130.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. M. Treluyer, S. Tonnelier, P. d'Athis, B. Leclerc, I. Jolivet-Landreau, and G. Pons
Antipyretic Efficacy of an Initial 30-mg/kg Loading Dose of Acetaminophen Versus a 15-mg/kg Maintenance Dose
Pediatrics, October 1, 2001; 108(4): e73 - 73.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
T. W. Hahn, S. W. Henneberg, R. J. Holm-Knudsen, K. Eriksen, S. N. Rasmussen, and M. Rasmussen
Pharmacokinetics of rectal paracetamol after repeated dosing in children
Br. J. Anaesth., October 1, 2000; 85(4): 512 - 519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Clinical Pharmacology